Page last updated: 2024-08-26
bosentan anhydrous and Experimental Pneumococcal Meningitis
bosentan anhydrous has been researched along with Experimental Pneumococcal Meningitis in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Christen, S; Ferriero, DM; Leib, SL; Pfister, LA; Shaw, S; Täuber, MG; Tureen, JH | 1 |
Other Studies
1 other study(ies) available for bosentan anhydrous and Experimental Pneumococcal Meningitis
| Article | Year |
|---|---|
Endothelin inhibition improves cerebral blood flow and is neuroprotective in pneumococcal meningitis.
Topics: Animals; Bosentan; Brain; Cell Count; Cerebrovascular Circulation; Disease Models, Animal; Endothelin-1; Female; Male; Meningitis, Pneumococcal; Neuroprotective Agents; Rats; Rats, Wistar; Sulfonamides | 2000 |